Prestige Consumer Healthc... (PBH)
Prestige Consumer Healthcare Statistics
Share Statistics
Prestige Consumer Healthcare has 49.54M shares outstanding. The number of shares has increased by -0.28% in one year.
| Shares Outstanding | 49.54M |
| Shares Change (YoY) | -0.28% |
| Shares Change (QoQ) | 0.27% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 48.94M |
| Failed to Deliver (FTD) Shares | 232 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 1.58M, so 3.18% of the outstanding shares have been sold short.
| Short Interest | 1.58M |
| Short % of Shares Out | 3.18% |
| Short % of Float | 4.61% |
| Short Ratio (days to cover) | 4.69 |
Valuation Ratios
The PE ratio is 17.04 and the forward PE ratio is 16.73. Prestige Consumer Healthcare's PEG ratio is -0.05.
| PE Ratio | 17.04 |
| Forward PE | 16.73 |
| PS Ratio | 3.17 |
| Forward PS | 3.4 |
| PB Ratio | 2.15 |
| P/FCF Ratio | 14.9 |
| PEG Ratio | -0.05 |
Enterprise Valuation
Prestige Consumer Healthcare has an Enterprise Value (EV) of 4.66B.
| EV / Sales | 4.14 |
| EV / EBITDA | 12.46 |
| EV / EBIT | 18.72 |
| EV / FCF | 19.47 |
Financial Position
The company has a current ratio of 3.2, with a Debt / Equity ratio of 0.69.
| Current Ratio | 3.2 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 3.05 |
| Debt / FCF | 4.76 |
| Interest Coverage | 5.1 |
Financial Efficiency
Return on Equity is 12.65% and Return on Invested Capital is 8.1%.
| Return on Equity | 12.65% |
| Return on Assets | 6.31% |
| Return on Invested Capital | 8.1% |
| Revenue Per Employee | $1.97M |
| Profits Per Employee | $367.26K |
| Employee Count | 570 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 3.61 |
Taxes
| Income Tax | 66.69M |
| Effective Tax Rate | 24.16% |
Stock Price Statistics
The stock price has increased by 17.28% in the last 52 weeks. The beta is 0.47, so Prestige Consumer Healthcare's price volatility has been higher than the market average.
| Beta | 0.47 |
| 52-Week Price Change | 17.28% |
| 50-Day Moving Average | 84.51 |
| 200-Day Moving Average | 77.12 |
| Relative Strength Index (RSI) | 41.24 |
| Average Volume (20 Days) | 369.8K |
Income Statement
In the last 12 months, Prestige Consumer Healthcare had revenue of 1.13B and earned 209.34M in profits. Earnings per share was 4.21.
| Revenue | 1.13B |
| Gross Profit | 624.45M |
| Operating Income | 342.43M |
| Net Income | 209.34M |
| EBITDA | 373.86M |
| EBIT | 343.19M |
| Earnings Per Share (EPS) | 4.21 |
Balance Sheet
The company has 46.47M in cash and 1.14B in debt, giving a net cash position of -1.09B.
| Cash & Cash Equivalents | 46.47M |
| Total Debt | 1.14B |
| Net Cash | -1.09B |
| Retained Earnings | 1.34B |
| Total Assets | 3.33B |
| Working Capital | 274.62M |
Cash Flow
In the last 12 months, operating cash flow was 248.93M and capital expenditures -9.55M, giving a free cash flow of 239.38M.
| Operating Cash Flow | 248.93M |
| Capital Expenditures | -9.55M |
| Free Cash Flow | 239.38M |
| FCF Per Share | 4.81 |
Margins
Gross margin is 55.49%, with operating and profit margins of 30.43% and 18.6%.
| Gross Margin | 55.49% |
| Operating Margin | 30.43% |
| Pretax Margin | 24.53% |
| Profit Margin | 18.6% |
| EBITDA Margin | 33.22% |
| EBIT Margin | 30.43% |
| FCF Margin | 21.27% |
Dividends & Yields
PBH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 5.87% |
| FCF Yield | 6.71% |
Analyst Forecast
The average price target for PBH is $98.5, which is 22.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $98.5 |
| Price Target Difference | 22.9% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 2.97 |
| Piotroski F-Score | 7 |